Menu

Be sure to take a good look at the pharmacy’s customer support and medicine service availability on Essenceapotek. You intend to make certain you contact MPs in many ways and that you can communicate all night to get to get assist if anything fails together with your medicine.

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" css=".vc_custom_1523021536010{margin-top: 20px !important;margin-right: 20px !important;margin-bottom: 50px !important;margin-left: 20px !important;}"][vc_column][vc_column_text] Über die Gewebebank Cells+Tissuebank Austria (C+TBA) und Sicherheitsstandards in Europa [/vc_column_text][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" css=".vc_custom_1523021536010{margin-top: 20px !important;margin-right: 20px !important;margin-bottom: 50px !important;margin-left: 20px !important;}"][vc_column][vc_column_text]Erstveröffentlichung: Implantologie Journal 12/17, Seiten 56-59, OEMUS MEDIA AG, Leipzig Am Beispiel der 2004 gegründeten „Cells+Tissuebank Austria, C+TBA“, die im dentalen Bereich exklusiv mit dem renommierten Unternehmen Straumann/botiss kooperiert, beschreibt der nachfolgende Beitrag den Weg von der Entnahme des Spendergewebes über dessen Aufbereitung zu allogenen Transplantaten bis hin zu Patienten in der implantologischen Praxis, die für eine Augmentation vorgesehen sind. Über Sicherheitsstandards in Europa, Screening-Verfahren und validierte Aufbereitungsverfahren informiert Mitbegründer und Geschäftsführer der C+TBA Martin Hennes im Gespräch mit Fachjournalistin und Zahnärztin Dr. Aneta Pecanov-Schröder.   [/vc_column_text][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" css=".vc_custom_1523174273936{margin-top: 30px !important;margin-right: 20px !important;margin-bottom: 30px !important;margin-left: 20px !important;}" z_index=""][vc_column][vc_column_text] Mehr als 30.000 allogene Knochentransplantationen werden in Deutschland...

Trajkovski et al. Hydrophilicity, Viscoelastic, and Physicochemical Properties Variations in Dental Bone Grafting Substitutes. Materials 2018, 11, 215. https://www.ncbi.nlm.nih.gov/pubmed/29385747 Study aim and design: In this publication the physico-chemical properties of different bone grafting materials were analyzed and compared. The evaluated characteristics comprised viscoelastic and hydrophilic properties, micro structure and chemical composition. Results: - Viscoelastic measurements affirmed that maxresorb® and cerabone® blocks are highly rigid and brittle also following rehydration, while the molecular mobility and therefore elastic properties of maxgraft® indicated to be particularly beneficial. - Analysis with a high speed camera showed that cerabone® and maxresorb® have the highest level of hydrophilicity, while blood uptake of Bio-Oss® and BoneCeramic® were much slower. - Micro computed tomography (µCT) and scanning electron microscopic (SEM) analysis demonstrated the highly porous structure of cerabone®, maxresorb® and maxgraft® and rough surface characteristic of cerabone® and maxresorb®. - Differences in the chemical composition of the bone grafts were demonstrated by infra-red spectroscopy (IR), x-ray powder diffractometry...

Jelusic et al. Monophasic ß-TCP vs. biphasic HA/ß-TCP in two-stage sinus floor augmentation procedures – a prospective randomized clinical trial. Clin. Oral Impl. Res. 0, 2016 / 1–9. https://www.ncbi.nlm.nih.gov/pubmed/27683073 The study compared of monophasic β-TCP (MBS) and biphasic β-TCP (maxresorb®) in maxillary sinus floor elevations using the lateral window technique. Biocompatibility, osteoconductivity and implant stability were analyzed histologically, radiologically and by resonance frequency analysis. Overall 60 patients were treated and 67 sinus lifts were performed. Results: Both monophasic and biphasic materials show good biocompatibility and osteoconductivity with satisfactory support on implant stability. Six months after sinus lift surgery the radiological volume of maxresorb® was significantly more stable than that of ß-TCP (6.66% vs. 22.2%). In addition, resonance frequency analysis endorsed a higher implant stability quotient for maxresorb® after six months....

Lorenz et al. Investigation of peri-implant tissue conditions and peri-implant tissue stability in implants placed with simultaneous augmentation procedure: a 3-year retrospective follow-up analysis of a newly developed bone level implant system. Int J Implant Dent. 2017 Dec; 3: 41. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585115/ Study aim and design: The study retrospectively analyzed the peri-implant tissue stability after implantation and simultaneous GBR with maxresorb® or pure beta-TCP material. 47 implants in 20 patients were clinically and radiologically evaluated 3 years after loading. Results: The implant survival rate 3 years after loading was 100%. Low median rates for probing depth, bleeding on probing, no osseous peri-implant defects and mean bone loss of 0.55 mm could be recorded. The authors concluded that implants placed in combination with a GBR procedure can achieve long-term stable functionally and aesthetically satisfying results....

Zafiropoulos et al. Changes of the peri‑implant soft tissue thickness after grafting with a collagen matrix. J Indian Soc Periodontol. 2016 Jul-Aug;20(4):441-445. https://www.ncbi.nlm.nih.gov/pubmed/28298828 Study aim and design: The study determined the treatment outcome of the use of mucoderm® to increase soft tissue volume as a part of implant site development. 27 patients were randomly assigned to one of two groups: mucoderm® (test) versus no biomaterial (control). The soft tissue thickness was measured at two different points at surgery and after 6 months. Results: The results showed a significant increase of the soft tissue thickness (STTh 1 = 1.06 mm, 117%; STTh 2 = 0.89 mm, 81%) in the test group. Biopsy results showed angiogenesis and mature connective tissue covered by keratinized epithelium. It was concluded that mucoderm® leads to a significant increase of peri-implant soft-tissue thickness, with good histological integration and replacement by soft tissue and may serve as an alternative to connective tissue grafting....

Vincent-Bugnas et al. Treatment of multiple maxillary adjacent class I and II gingival recessions with modified coronally advanced tunnel and a new xenogeneic acellular dermal matrix. J Esthet Restor Dent. 2017 Sep 13. https://www.ncbi.nlm.nih.gov/pubmed/28901687 Study aim and design: The study aimed to evaluate the treatment of maxillary Miller Class I and II multiple adjacent gingival recessions using the modified coronally advanced tunnel technique (MCAT) combined with muocderm®. 12 patients exhibiting at least 6 adjacent recessions were treated. Results: At 12 months, complete root coverage was obtained in 43% of the 100 gingival recessions, while the mean root coverage measured 84.35%. All patients were satisfied with the aesthetic appearance and would undergo the same surgery again. The authors concluded that treatment of Miller Class I and II multiple gingival recessions using mucoderm® in conjunction with the MCAT could be successfully used as an alternative to connective tissue grafts, with the advantage of avoiding the discomfort and morbidity of...

Fujioka-Kobayashi et al. In vitro evaluation of an injectable biphasic calcium phosphate (BCP) carrier system combined with recombinant human bone morphogenetic protein (rhBMP)-9. Bio-Medical Materials and Engineering 28 (2017) 293–304. https://www.ncbi.nlm.nih.gov/pubmed/28527192 Study aim and design: The study evaluated the possibility of combining maxresorb® inject with growth factors by analyzing adsorption of rhBMP9 as well as adhesion, proliferation, viability and differentiation of stromal cells. Results: The results demonstrated that maxresorb inject serves as an excellent carrier for the growthfactors. The bone paste showed very good adsorption/retention potential of rhBMP9 with a slow and steady release over a 10 day period. The combination of maxresorb® inject and rhBMP9 demonstrated a good osteoinductive potential by positively influencing the osteoblastic differentiation of stromal cells....

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" css=".vc_custom_1513510348027{margin-right: 20px !important;margin-left: 20px !important;}"][vc_column][vc_column_text css=".vc_custom_1513511719795{margin-bottom: 60px !important;}"]To commemorate the receipt of the CE marking certification of cerabone® 15 years ago, five leading experts, with extensive experience in the field of dental bone regeneration and a solid clinical experience with cerabone®, gathered to discuss all relevant aspects of the clinical performance of the bone grafting material. The debate predominantly focused on the clinical indications of cerabone® and its handling. The goal of the meeting was to develop an indication-based guideline for the clinical use of cerabone®, i.e. which basic principles should be followed when using cerabone® for different bone augmentation procedures. Experts invited were Assoc. Prof. Dr. Ziv Mazor (Raanana, Israel), Dr. Alessandro Rossi (University of Milan, Italy), Dr. Pedro Lázaro Calvo (Madrid, Spain), PD Dr. mult. Peer Kämmerer (University Medical Centre Rostock, Germany) and Dr. Marko Blašković (Rijeka, Croatia).[/vc_column_text][vc_separator type="normal" color="#999999" up="20px"][vc_accordion active_tab="false"...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] Healing of localized gingival recessions treated with a coronally advanced flap alone or combined with an enamel matrix derivative and a porcine acellular dermal matrix: a preclinical study. Shirakata et al. Clin Oral Investig. 2016 Sep;20(7):1791-800. https://www.ncbi.nlm.nih.gov/pubmed/26612398 Principal finding: The combined use of mucoderm® and Emdogain® in coronally advanced flap procedures may promote periodontal regeneration in gingival recession defects. [/vc_column_text][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" padding_top="20px" padding_bottom="20px"][vc_column][vc_separator type="normal" color="#00ccff"][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] Collagen Membranes Adsorb the Transforming Growth Factor-β Receptor I Kinase-Dependent Activity of Enamel Matrix Derivative. Stähli et al. J Periodontol. 2016 May;87(5):583-90. https://www.ncbi.nlm.nih.gov/pubmed/?term=st%C3%A4hli+collagen+membranes Principal finding: mucoderm® has the ability to adsorb the TGF-β activity intrinsic to Emdogain® and makes it available for oral fibroblasts.[/vc_column_text][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" padding_top="20px" padding_bottom="20px"][vc_column][vc_separator type="normal" color="#00ccff"][/vc_column][/vc_row][vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] Biofunctionalization of porcine-derived collagen matrix using enamel matrix derivative and platelet-rich fibrin:...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" css=".vc_custom_1509384895058{padding-right: 50px !important;padding-left: 50px !important;}"][vc_column][vc_column_text]This case report describes the predictable coverage of multiple adjacent maxillary gingival recessions using the modified coronally advanced flap (MCAF) technique and modified coronally advanced tunnel technique (MCAT) in conjunction with an acellular porcine-derived collagen matrix (mucoderm®) combined with enamel matrix derivative (Straumann® Emdogain®). The author states: "In my opinion, this case can be viewed as satisfactory both for the patient and the operator, effectively demonstrating the benefits of the combination of mucoderm® and Emdogain® as regards time and pain."[/vc_column_text][vc_column_text] Initial situation A 30-year old female patient in good general health conditions presented with Miller Class I gingival recessions in the upper jaw affecting the teeth #12, #13 and #14 and teeth #22, #23 and #24 (Figs. 1-3), and was referred to our office by an orthodontist colleague (Enikő Szívos, DMD, orthodontist). The patient sought a minimally invasive approach to...